Applied Therapeutics Balance Sheet (2023-2025) | APLT

Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 22.92M35.62M37.50M49.90M146.50M122.20M98.90M79.40M50.80M30.42M11.95M
Receivables - Other 0.02M0.02M0.02M0.02M16.65M
Prepaid Assets 6.15M7.21M7.03M4.23M4.17M5.12M5.48M4.25M3.20M4.09M19.71M
Current Assets 29.06M42.82M44.49M54.39M150.91M127.57M104.60M83.65M53.97M34.51M31.65M
Non-Current Assets
Non-Current Assets 0.94M0.82M0.71M0.45M0.33M0.21M1.96M3.04M2.94M2.83M2.72M
Assets 30.00M43.65M45.20M54.83M151.23M127.78M106.57M86.69M56.91M37.34M34.37M
Liabilities
Current Liabilities
Accounts Payables 5.55M4.69M6.00M1.74M4.02M2.68M2.84M4.43M4.87M4.86M4.80M
Payables 5.55M4.69M6.00M1.74M4.02M2.68M2.84M4.43M4.87M4.86M4.80M
Accumulated Expenses 14.03M16.02M12.24M15.29M14.64M10.30M13.49M16.14M9.46M10.67M23.49M
Current Leases 0.48M0.49M0.49M0.43M0.31M0.18M0.26M0.41M0.43M0.45M0.47M
Total Current Liabilities 33.25M47.19M55.50M71.18M83.91M55.36M98.97M27.30M17.96M17.75M32.90M
Non-Current Liabilities
Operating Leases 0.29M0.17M0.04M0.04M0.04M0.03M1.71M2.39M2.27M2.15M2.03M
Total Non-Current Liabilities 0.82M0.79M0.73M0.80M0.04M0.03M1.71M2.39M2.27M2.15M2.03M
Total Liabilities 34.08M47.98M56.24M71.98M83.94M55.39M100.67M29.68M20.24M19.90M34.94M
Shareholder's Equity
Common Equity -4.07M-4.33M-11.04M-17.15M67.29M72.39M5.89M57.01M36.67M17.44M-0.56M
Shareholder's Equity -4.07M-4.33M-11.04M-17.15M67.29M72.39M5.89M57.01M36.67M17.44M-0.56M
Liabilities and Shareholders Equity 30.00M43.65M45.20M54.83M151.23M127.78M106.57M86.69M56.91M37.34M34.37M
Retained Earnings -359.00M-388.54M-430.91M-468.59M-552.52M-549.63M-618.22M-574.21M-596.03M-617.40M-636.40M
Treasury Shares 3.26M3.45M3.33M6.53M6.34M6.21M3.72M5.13M5.05M4.83M
Shares Outstanding 48.11M62.12M77.13M84.87M114.24M114.85M116.36M137.23M141.58M141.94M144.30M